Syndax Pharmaceuticals (SNDX) Q2 2026 Earnings

Apr 30Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.25
-0.99
-0.74
-0.48

Details

Expected EPS
-0.60776
Actual EPS
-0.48
Surprise EPS
0.13
Surprise Percent
+21.02%

Description

⁨Syndax Pharmaceuticals⁩ (⁦SNDX⁩) has reported earnings of ⁦-0.48⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts